CYTO Message Board - Msg: 13629630

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (7861)	5/8/2000 12:06:00 PM
From: Jim Oravetz	Read Replies (2) of 8116

Cytogen Corp. - Princeton, N.J. 1st Quar March 31: 2000 1999 Revenue $2,428,000 $2,324,000 Net income (1,961,000) a 1,657,000 Avg shrs (basic) 71,630,000 64,192,000 Avg shrs (diluted) 71,630,000 64,496,000 Shr earns (basic) Net income (.03) a .03 Shr earns (diluted) Net income (.03) a .03 Figures in parentheses are losses. a. Includes a gain of $3.3 million, or 5 cents a share, on the sale of manufacturing and laboratory facilities. Cytogen Corp. (CYTO) develops cancer treatment products.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next